Formulation Development and Evaluation of Fast Disintegrating Tablets of Cetirizine Hydrochloride
Year: 2026
Type: article
Abstract: Fast disintegrating tablets have attracted significant interest as a convenient alternative to conventional tablets because they break down quickly in the mouth and can be taken without water. This makes them especially beneficial for patients who have difficulty swallowing, including children, elderly individuals, and those with certain medical conditions. Cetirizine hydrochloride, a widely used second-generation antihistamine for allergic disorders, is a suitable drug candidate for formulation as a fast disintegrating tablet. This review discusses the development and evaluation of cetirizine hydrochloride fast disintegrating tablets based on published literature. It focuses on the selection of the drug and excipients, the type and concentration of super disintegrants used, formulation techniques, and the key factors that influence tablet performance. Attention is given to natural and synthetic super disintegrants, including plant-derived mucilages, which show promise as natural pharmaceutical excipients for achieving rapid tablet disintegration and drug release. Different formulation methods, especially direct compression, are reviewed along with the roles of diluents, binders, lubricants, glidants, sweeteners, and flavouring agents. Common evaluation tests such as weight variation, hardness, friability, wetting time, disintegration time, drug content, and in-vitro dissolution are also discussed. Previous studies suggest that careful selection and optimization of super disintegrants and other excipients are essential to produce tablets with adequate mechanical strength, rapid disintegration, and effective drug release. The review further highlights the potential of combining natural and synthetic super disintegrants for future development of cetirizine hydrochloride fast disintegrating tablets.
Institution: Dr. Babasaheb Ambedkar Technological University
Language: English
Subfield: Pharmaceutical Science
Domain: Life Sciences
Open Access status: green
OpenAlex ID: W7236085046
